KKR said it had agreed to pick up a minority stake in Indian generic injectable pharmaceutical products company Gland Pharma for about $200 million.
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303562904579225281034326994.html?mod=pls_whats_news_us_business_f
via IFTTT
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303562904579225281034326994.html?mod=pls_whats_news_us_business_f
via IFTTT
No comments:
Post a Comment